Trillium Therapeutics Company Profile (NASDAQ:TRIL)

About Trillium Therapeutics

Trillium Therapeutics logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TRIL
  • CUSIP:
Key Metrics:
  • Previous Close: $14.15
  • 50 Day Moving Average: $9.76
  • 200 Day Moving Average: $9.54
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.85
  • P/E Growth: 0.00
  • Market Cap: $110.57M
  • Outstanding Shares: 7,814,000
  • Beta: 1.92
Additional Links:
Companies Related to Trillium Therapeutics:

Analyst Ratings

Consensus Ratings for Trillium Therapeutics (NASDAQ:TRIL) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $25.33 (79.03% upside)

Analysts' Ratings History for Trillium Therapeutics (NASDAQ:TRIL)
Show:
DateFirmActionRatingPrice TargetDetails
8/15/2016Leerink SwannReiterated RatingOutperform$20.00View Rating Details
8/3/2016Ladenburg ThalmannInitiated CoverageBuy$18.00View Rating Details
6/12/2016Cowen and CompanyReiterated RatingBuyView Rating Details
6/6/2016Oppenheimer Holdings Inc.Reiterated RatingBuy$38.00View Rating Details
(Data available from 8/23/2014 forward)

Earnings

Earnings History for Trillium Therapeutics (NASDAQ:TRIL)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Trillium Therapeutics (NASDAQ:TRIL)
Current Year EPS Consensus Estimate: $-2.77 EPS
Next Year EPS Consensus Estimate: $-2.42 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.61)($0.61)($0.61)
Q2 20161($0.71)($0.71)($0.71)
Q3 20161($0.81)($0.81)($0.81)
Q4 20161($0.91)($0.91)($0.91)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Trillium Therapeutics (NASDAQ:TRIL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Trillium Therapeutics (NASDAQ:TRIL)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Trillium Therapeutics (NASDAQ:TRIL)
DateHeadline
reuters.com logoBRIEF-Trillium Therapeutics' TTI-621 receives FDA clearance to proceed in clinical trial (NASDAQ:TRIL)
www.reuters.com - August 17 at 10:50 AM
finance.yahoo.com logoTrillium Therapeutics Receives FDA Clearance to Proceed With TTI-621 in Clinical Trial Targeting Solid Tumors and Mycosis Fungoides (NASDAQ:TRIL)
finance.yahoo.com - August 17 at 10:50 AM
finance.yahoo.com logoCoverage initiated on Trillium Therapeutics by Ladenburg Thalmann (NASDAQ:TRIL)
finance.yahoo.com - August 3 at 8:14 PM
investornewswire.com logoStrong Sell Calls Recommendations For Trillium Therapeutics Inc. (NASDAQ:TRIL) At 0 - Investor Newswire (NASDAQ:TRIL)
www.investornewswire.com - June 25 at 11:34 AM
fiscalstandard.com logoRecently Issued Stock Ratings For Trillium Therapeutics Inc. (TRIL) - Fiscal Standard (NASDAQ:TRIL)
www.fiscalstandard.com - June 24 at 7:55 PM
stocksdaily.net logoCan Trillium Therapeutics Inc. (NASDAQ:TRIL) Meet Analysts Expectations? - Stocks Daily (NASDAQ:TRIL)
www.stocksdaily.net - June 20 at 9:18 AM
fiscalstandard.com logoTrillium Therapeutics Inc. (TRIL) Analyst Price Targets For The Coming Week - Fiscal Standard (NASDAQ:TRIL)
www.fiscalstandard.com - June 20 at 9:18 AM
investornewswire.com logoStrong Buy Calls Count For Trillium Therapeutics Inc. (NASDAQ:TRIL) At 3 - Investor Newswire (NASDAQ:TRIL)
www.investornewswire.com - June 18 at 9:22 AM
kcregister.com logoDon't Miss: Trillium Therapeutics (NASDAQ:TRIL), Echo (NASDAQ:ECTE), IMS Health (NYSE:IMS), Ashford Hospitality ... - KC Register (NASDAQ:TRIL)
www.kcregister.com - June 14 at 8:34 AM
capitalcube.com logoTrillium Therapeutics, Inc. :TRIL-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 (NASDAQ:TRIL)
www.capitalcube.com - June 8 at 6:08 PM
News IconTrillium Therapeutics Inc's Stock Is Buy After Today's Huge Increase - HNN (NASDAQ:TRIL)
hintsnewsnetwork.com - June 2 at 8:25 PM
News IconTrillium Therapeutics Inc. (NASDAQ:TRIL)'s Company Shares Increased 1.10% After High Volatility - HNN (NASDAQ:TRIL)
hintsnewsnetwork.com - June 1 at 8:37 PM
News IconStock Review and Earnings Check on Trillium Therapeutics Inc. (NASDAQ:TRIL) - HNN (NASDAQ:TRIL)
hintsnewsnetwork.com - June 1 at 10:53 AM
News IconTrillium Therapeutics Inc. (NASDAQ:TRIL) Stock Update & Estimates - Stock Tick Tock (NASDAQ:TRIL)
www.stockticktock.com - May 31 at 8:18 PM
News IconBroker Outlook For The Week Ahead: Trillium Therapeutics Inc. (TRIL) - Share Trading News (NASDAQ:TRIL)
www.sharetrading.news - May 30 at 9:54 PM
News IconEarnings Review and Stock Rundown for Trillium Therapeutics Inc. (NASDAQ:TRIL) - Wall Street Hints and News (NASDAQ:TRIL)
hintsnewsnetwork.com - May 26 at 2:59 PM
stocksdaily.net logoCan Trillium Therapeutics Inc. (NASDAQ:TRIL) Top Street's Expectations? - Stocks Daily (NASDAQ:TRIL)
www.stocksdaily.net - March 13 at 3:00 PM
News IconTrillium Therapeutics posts loss of $2.2 million in fourth quarter - The Province (NASDAQ:TRIL)
www.theprovince.com - March 11 at 2:57 PM
News IconTrillium Therapeutics Inc. Pipeline Review, Market Growth, Segment, Trends and Forecast 2016 – 2020 - Medgadget.com (blog) (NASDAQ:TRIL)
www.medgadget.com - March 11 at 2:57 PM
News IconTemporary foreign worker from Mexico reaches settlement with owner of Langley blueberry farm (NASDAQ:TRIL)
www.theprovince.com - March 11 at 2:57 PM
News IconTrillium Therapeutics posts loss of $2.2 million in fourth quarter (NASDAQ:TRIL)
www.vancouversun.com - March 11 at 2:57 PM
finance.yahoo.com logoTrillium Announces a $3.4 Million Government Co-Funded Translational Research Program (NASDAQ:TRIL)
finance.yahoo.com - March 10 at 9:00 AM
sg.finance.yahoo.com logoTrillium reports 4Q loss (NASDAQ:TRIL)
sg.finance.yahoo.com - March 9 at 6:28 PM
finance.yahoo.com logoTrillium Reports 2015 Financial and Operating Results (NASDAQ:TRIL)
finance.yahoo.com - March 9 at 5:30 PM
finance.yahoo.com logoTrillium to Present at the Cowen and Company 36th Annual Health Care Conference (NASDAQ:TRIL)
finance.yahoo.com - March 8 at 7:00 AM
wallstreet.org logoStock Rating & Analysis on Trillium Therapeutics Inc. (NASDAQ:TRIL) - WallStreet.org (NASDAQ:TRIL)
www.wallstreet.org - March 5 at 2:25 PM
News IconTrillium Therapeutics Inc. (TRIL) Updated Price Targets - Share Trading News (NASDAQ:TRIL)
www.sharetrading.news - March 3 at 2:47 PM
News IconWhat's Ahead for Trillium Therapeutics Inc. After Today's Huge Decline? - Business Standard Tribune (NASDAQ:TRIL)
www.standardtrib.com - March 1 at 2:50 PM
News IconTrillium Therapeutics Inc Stock Price Increases Today - RiversideGazette.com (NASDAQ:TRIL)
www.riversidegazette.com - February 27 at 2:12 PM
finance.yahoo.com logoTrillium Therapeutics Inc. (TRIL) (NASDAQ:TRIL)
finance.yahoo.com - February 18 at 2:16 PM
finance.yahoo.com logoTrillium Therapeutics Doses First Patient With TTI-621, a Novel Immune Checkpoint Inhibitor Targeting CD47 (NASDAQ:TRIL)
finance.yahoo.com - February 3 at 7:00 AM
streetinsider.com logoTrillium Therapeutics (TRIL) Acquires Privately-Held Fluorinov Pharma (NASDAQ:TRIL)
www.streetinsider.com - January 30 at 1:49 PM
finance.yahoo.com logoTrillium Therapeutics Acquires Fluorinov Pharma (NASDAQ:TRIL)
finance.yahoo.com - January 28 at 8:00 AM
streetinsider.com logoTrillium Therapeutics (TRIL) Acquires Oncology Company Fluorinov Pharma (NASDAQ:TRIL)
www.streetinsider.com - January 27 at 1:34 PM
finance.yahoo.com logo8:16 am Trillium Therapeutics acquires Fluorinov Pharma for ~$7 mln, plus up to ~$25 mln of additional future payments that are contingent on Trillium achieving certain clinical and regulatory milestones (NASDAQ:TRIL)
finance.yahoo.com - January 27 at 8:16 AM
finance.yahoo.com logoTrillium Acquires Privately-Held Fluorinov Pharma Inc. (NASDAQ:TRIL)
finance.yahoo.com - January 27 at 8:13 AM
finance.yahoo.com logoTRILLIUM THERAPEUTICS INC. Financials (NASDAQ:TRIL)
finance.yahoo.com - December 8 at 1:08 PM
finance.yahoo.com logoTrillium to Provide Update on CD47 Immune Checkpoint Inhibitor Program at the 2015 American Society of Hematology Annual Meeting (NASDAQ:TRIL)
finance.yahoo.com - December 3 at 7:00 AM
insidermonkey.com logoIs Cumberland Pharmaceuticals, Inc. (CPIX) A Good Stock To Buy? (NASDAQ:TRIL)
www.insidermonkey.com - November 28 at 11:30 AM
insidermonkey.com logoShould You Buy General Finance Corporation (GFN)? (NASDAQ:TRIL)
www.insidermonkey.com - November 25 at 12:41 PM
finance.yahoo.com logoThree Canadian Biotechs with Pending Catalysts (NASDAQ:TRIL)
finance.yahoo.com - October 14 at 12:02 AM
finance.yahoo.com logoTrillium Therapeutics Provides Update on CD47 Program (NASDAQ:TRIL)
finance.yahoo.com - September 30 at 7:00 AM
finance.yahoo.com logoOne of the quietest days of the year on Wall Street... (NASDAQ:TRIL)
finance.yahoo.com - May 15 at 4:40 PM
insidermonkey.com logoBreaking Down Steve Cohen’s Four Latest Moves in Sarepta Therapeutics (SRPT), Smith & Wesson (SWHC), More (NASDAQ:TRIL)
www.insidermonkey.com - May 5 at 11:48 AM
insidermonkey.com logoRidgeback Capital’s Latest Healthcare Picks: Cara Therapeutics, Trillium Therapeutics and More (NASDAQ:TRIL)
www.insidermonkey.com - April 24 at 1:51 PM
finance.yahoo.com logoSteven Cohen Buys Trillium Therapeutics and Boosts Stake in Smith & Wesson Corp (NASDAQ:TRIL)
finance.yahoo.com - April 24 at 12:08 AM
insidermonkey.com logoAegerion Pharmaceuticals, Inc. (AEGR), Joint Corp (JYNT), Trillium Therapeutics Inc. (TRIL): Latest Fund Moves in the Hot Healthcare Sector (NASDAQ:TRIL)
www.insidermonkey.com - April 2 at 4:02 PM
247wallst.com logoBiotechs Raising New Capital in Droves (NASDAQ:TRIL)
247wallst.com - April 1 at 11:20 AM
thestreet.com logoSo Far in 2015, This Choppy Market Is for Stock-Picker's Only (NASDAQ:TRIL)
www.thestreet.com - January 28 at 1:55 PM

Social

Trillium Therapeutics (NASDAQ:TRIL) Chart for Tuesday, August, 23, 2016


Last Updated on 8/23/2016 by MarketBeat.com Staff